drugset / Trial / NCT00387491

Dose Ranging Study in Healthy Methadone Maintenance Subjects

NCT00387491

Phase 1 Completed 16 enrolled Bausch Health Americas, Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

Timeline

Start
2006-06
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified Oral

Indications

No indication recorded.